Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 10Unknown 2Terminated 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Sarcoma 8Stomach Neoplasms 7Esophageal Neoplasms 7Breast Neoplasms 7Neoplasms 5Lung Neoplasms 5Hypopharyngeal Neoplasms 5Carcinoma, Hepatocellular 5Recurrence 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Neoplasm Metastasis 4Thyroid Neoplasms 3Nasopharyngeal Carcinoma 3Melanoma 3Laryngeal Neoplasms 3Head and Neck Neoplasms 3Glioma 3Glioblastoma 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Osteosarcoma 2Mouth Neoplasms 2Hyperthermia 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2

Interventions

pembrolizumab 3Temozolomide 3Specimen Handling 3Radiotherapy 2peposertib 1liposomal doxorubicin 1gosha-jinki-gan 1efineptakin alfa 1cabozantinib 1balstilimab 1atezolizumab 1abexinostat 1Surgical Procedures, Operative 1Radiation 1ONC206 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Gliosarcoma × Surgical Procedures, Operative × Clear all
NCT07301268 2026-04-08

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Mayo Clinic

Phase 2 Recruiting
36 enrolled
CNSSarcoma

Astrocytoma, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡